@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix massbank: <https://identifiers.org/massbank/> .
@prefix mbo: <http://www.massbank.jp/ontology/> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix schema: <https://schema.org/> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

massbank:MSBNK-ACES_SU-AS000068 a mbo:MassSpectrum ;
    dcterms:creator "ACESx, Jonathan W. Martin Group" ;
    dcterms:date "2022-08-15"^^xsd:date ;
    dcterms:identifier "MSBNK-ACES_SU-AS000068" ;
    dcterms:license <https://creativecommons.org/licenses/by/4.0/> ;
    dcterms:rights "Stockholm University, ACESx, Jonathan W. Martin Group (C) 2022 under CC BY" ;
    mbo:analytical_methods_and_conditions [ a mbo:AnalyticalMethods ;
            mbo:ac_instrument "QExactive Orbitrap HF-X (Thermo Scientific)" ;
            mbo:collision_energy "Ramp 20%-70% (nominal)" ;
            mbo:column_name "Waters; Acquity UPLC BEH C18, 2.1 x 100 mm, 1.7 um, Waters" ;
            mbo:flow_gradient "98/2 at 4.2 min, 0/100 at 22 min, 0/100 at 25 min, 98/2 at 25.1 min, 98/2 at 30 min" ;
            mbo:flow_rate "0.45mL/min" ;
            mbo:fragmentation_mode "HCD" ;
            mbo:instrument_type "LC-APCI-QFT" ;
            mbo:ion_mode "NEGATIVE" ;
            mbo:ms_type "MS2" ;
            mbo:resolution "30000" ;
            mbo:retention_time "6.575500" ;
            mbo:solvent "A 1 mM ammonium fluoride in water",
                "B MeOH" ] ;
    mbo:compound [ a schema:chemicalsubstance ;
            rdfs:label "4-amino-N-pyrimidin-2-ylbenzenesulfonamide",
                "Sulfadiazine" ;
            mbo:ch_compound_class "Drugs; Antiinfective Agents; Amines; Aniline Compounds; Sulfanilamides" ;
            mbo:ch_exact_mass 2.500524e+02 ;
            schema:inChI "InChI=1S/C10H10N4O2S/c11-8-2-4-9(5-3-8)17(15,16)14-10-12-6-1-7-13-10/h1-7H,11H2,(H,12,13,14)" ;
            schema:molecularFormula "C10H10N4O2S" ;
            schema:name "4-amino-N-pyrimidin-2-ylbenzenesulfonamide",
                "Sulfadiazine" ;
            schema:smiles "O=S(=O)(NC1=NC=CC=N1)C2=CC=C(N)C=C2" ] ;
    mbo:has_peak [ mbo:intensity 5.9526e+04 ;
            mbo:mz 6.50146e+01 ;
            mbo:peak_sequential_number 1 ;
            mbo:relative_intensity 9 ],
        [ mbo:intensity 1.12677e+05 ;
            mbo:mz 1.860842e+02 ;
            mbo:peak_sequential_number 10 ;
            mbo:relative_intensity 18 ],
        [ mbo:intensity 2.81944e+05 ;
            mbo:mz 1.860869e+02 ;
            mbo:peak_sequential_number 11 ;
            mbo:relative_intensity 44 ],
        [ mbo:intensity 6.7716e+04 ;
            mbo:mz 2.142543e+02 ;
            mbo:peak_sequential_number 12 ;
            mbo:relative_intensity 11 ],
        [ mbo:intensity 5.3726e+04 ;
            mbo:mz 2.142657e+02 ;
            mbo:peak_sequential_number 13 ;
            mbo:relative_intensity 8 ],
        [ mbo:intensity 6.0078e+04 ;
            mbo:mz 2.220342e+02 ;
            mbo:peak_sequential_number 14 ;
            mbo:relative_intensity 9 ],
        [ mbo:intensity 6.33049e+06 ;
            mbo:mz 2.490452e+02 ;
            mbo:peak_sequential_number 15 ;
            mbo:relative_intensity 999 ],
        [ mbo:intensity 6.15579e+05 ;
            mbo:mz 2.500486e+02 ;
            mbo:peak_sequential_number 16 ;
            mbo:relative_intensity 97 ],
        [ mbo:intensity 6.6508e+04 ;
            mbo:mz 2.509418e+02 ;
            mbo:peak_sequential_number 17 ;
            mbo:relative_intensity 10 ],
        [ mbo:intensity 1.74697e+05 ;
            mbo:mz 2.510405e+02 ;
            mbo:peak_sequential_number 18 ;
            mbo:relative_intensity 28 ],
        [ mbo:intensity 8.60977e+05 ;
            mbo:mz 9.202556e+01 ;
            mbo:peak_sequential_number 2 ;
            mbo:relative_intensity 136 ],
        [ mbo:intensity 1.67017e+05 ;
            mbo:mz 9.303342e+01 ;
            mbo:peak_sequential_number 3 ;
            mbo:relative_intensity 26 ],
        [ mbo:intensity 6.10749e+05 ;
            mbo:mz 9.404103e+01 ;
            mbo:peak_sequential_number 4 ;
            mbo:relative_intensity 96 ],
        [ mbo:intensity 5.6917e+04 ;
            mbo:mz 1.469706e+02 ;
            mbo:peak_sequential_number 5 ;
            mbo:relative_intensity 9 ],
        [ mbo:intensity 7.7016e+04 ;
            mbo:mz 1.580726e+02 ;
            mbo:peak_sequential_number 6 ;
            mbo:relative_intensity 12 ],
        [ mbo:intensity 7.2254e+04 ;
            mbo:mz 1.809407e+02 ;
            mbo:peak_sequential_number 7 ;
            mbo:relative_intensity 11 ],
        [ mbo:intensity 1.214534e+06 ;
            mbo:mz 1.85081e+02 ;
            mbo:peak_sequential_number 8 ;
            mbo:relative_intensity 192 ],
        [ mbo:intensity 2.719686e+06 ;
            mbo:mz 1.850838e+02 ;
            mbo:peak_sequential_number 9 ;
            mbo:relative_intensity 429 ] ;
    mbo:mass_spectram_meta_data [ a mbo:MassSpectramMetaData ;
            mbo:base_peak 2.490452e+02 ;
            mbo:precursor_mz_value "249.0451"^^xsd:float ] ;
    mbo:pk_num_peak 18 ;
    mbo:pk_splash "splash10-000b-2590000000-26748ca9cd42d7b483dc" ;
    rdfs:comment "CONFIDENCE Standard Compound (Level 1)" ;
    skos:definition "Sulfadiazine; LC-APCI-QFT; MS2; CE: Ramp 20%-70% (nominal); R=30000; [M-H]-" .

